Blood Work in Hypertensive Emergency
Obtain a comprehensive laboratory panel immediately including hemoglobin, platelets, creatinine, sodium, potassium, LDH, haptoglobin, quantitative urinalysis for protein, and urine sediment examination for erythrocytes, leukocytes, cylinders and casts. 1
Essential Laboratory Tests
The diagnostic workup must focus on detecting acute hypertension-mediated organ damage across multiple systems:
Core Laboratory Panel
- Complete blood count: Hemoglobin and platelet count to assess for microangiopathic hemolytic anemia and thrombocytopenia, which indicate thrombotic microangiopathy 1, 2
- Renal function: Creatinine, sodium, and potassium to evaluate for acute kidney injury 1, 2
- Hemolysis markers: LDH and haptoglobin to detect hemolysis in hypertensive thrombotic microangiopathy 1, 2
- Urinalysis: Quantitative protein measurement and urine sediment examination for erythrocytes, leukocytes, cylinders and casts to identify renal damage 1, 2
Additional Tests Based on Clinical Presentation
- Cardiac markers: Troponin-T, CK, CK-MB if chest pain is present to evaluate for acute coronary syndrome 1, 2
- Peripheral blood smear: For assessment of schistocytes when thrombotic microangiopathy is suspected 1, 2
Diagnostic Examinations
Beyond laboratory work, the following are essential:
- ECG: To detect ischemia, arrhythmias, or left ventricular hypertrophy 1, 2
- Fundoscopy: Should be performed when malignant hypertension is suspected to identify retinal hemorrhages, cotton wool spots, and papilledema 1, 2
Conditional Studies
- Chest X-ray or point-of-care ultrasound: For suspected fluid overload or pulmonary edema 1
- Transthoracic echocardiography: To assess cardiac structure and function 1
- CT or MRI brain: If intracranial hemorrhage or hypertensive encephalopathy is suspected 1
- CT-angiography of thorax and abdomen: For suspected acute aortic disease 1
- Renal ultrasound: To evaluate for postrenal obstruction, kidney size, or left-to-right differences 1
Initial Treatment Approach
Admit immediately to an intensive care unit for continuous blood pressure monitoring and initiate parenteral antihypertensive therapy. 1, 2
Blood Pressure Targets
- Standard approach: Reduce mean arterial pressure by 20-25% within the first hour, then if stable reduce to 160/100 mmHg over 2-6 hours, then cautiously normalize over 24-48 hours 1, 2
- Aortic dissection exception: Target systolic BP <120 mmHg and heart rate <60 bpm immediately 2
- Acute coronary syndrome: Target systolic BP <140 mmHg immediately 2
First-Line IV Medications
- Nicardipine: 5 mg/hr initially, titrate by 2.5 mg/hr every 15 minutes to maximum 15 mg/hr 2, 3
- Labetalol: 0.25-0.5 mg/kg IV bolus or 2-4 mg/min continuous infusion 2
- Clevidipine: 1-2 mg/hr initially, doubling every 90 seconds until BP approaches target 2
Critical Pitfalls to Avoid
- Do not reduce BP to normal acutely: Patients with chronic hypertension have altered cerebral autoregulation and cannot tolerate acute normalization—this can precipitate cerebral, renal, or coronary ischemia 1, 2
- Avoid excessive drops >70 mmHg systolic: This may cause acute renal injury and early neurological deterioration 1, 2
- Do not delay laboratory testing: Immediate assessment is crucial for appropriate management 2
- Recognize that BP may fall spontaneously: Repeated measurements should be performed over time, as BP will fall considerably without medication in a significant proportion of patients 1
- Focus on rate of BP rise, not absolute value: The rate of BP increase is more important than the absolute BP value in development of hypertensive emergencies 1
Post-Stabilization Considerations
After initial stabilization, screen for secondary causes of hypertension (found in 20-40% of malignant hypertension cases), including renal artery stenosis, pheochromocytoma, and primary aldosteronism 2. Address medication non-adherence, the most common trigger for hypertensive emergencies 2.